Related references
Note: Only part of the references are listed.Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
Yajing Fu et al.
VIROLOGICA SINICA (2020)
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19
Alfred H. J. Kim et al.
ANNALS OF INTERNAL MEDICINE (2020)
Updated Approaches against SARS-CoV-2
Haiou Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
COVID-19 infection and rheumatoid arthritis: Faraway, so close!
Ennio Giulio Favalli et al.
AUTOIMMUNITY REVIEWS (2020)
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
Wen Zhang et al.
CLINICAL IMMUNOLOGY (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action
Claudio Conforti et al.
DERMATOLOGIC THERAPY (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
Dan Zhou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
SARS-CoV-2: a storm is raging
Savannah F. Pedersen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Should patients stop their biologic treatment during the COVID-19 pandemic
Arjun M. Bashyam et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2020)
COVID-19 and immunomodulator/immunosuppressant use in dermatology
Kyla N. Price et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Should biologics for psoriasis be interrupted in the era of COVID-19?
Mark Lebwohl et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Cutaneous manifestations in COVID-19: a first perspective
S. Recalcati
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
Lorenzo D'Antiga
LIVER TRANSPLANTATION (2020)
Use of systemic immunomodulatory therapies during the coronavirus disease 2019 (COVID-19) pandemic
Payal Shah et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic
Eakachai Prompetchara et al.
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY (2020)
A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
Sin-Yee Fung et al.
EMERGING MICROBES & INFECTIONS (2020)
Systemic rheumatic diseases: From biological agents to small molecules
Piercarlo Sarzi-Puttini et al.
AUTOIMMUNITY REVIEWS (2019)
The protective and pathogenic roles of IL-17 in viral infections: friend or foe?
Wen-Tao Ma et al.
OPEN BIOLOGY (2019)
Systemic Corticosteroid Therapy May Delay Viral Clearance in Patients with Middle East Respiratory Syndrome Coronavirus Infection
David S. Hui
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Gina A. Montealegre Sanchez et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission
David S. Hui et al.
LANCET INFECTIOUS DISEASES (2018)
Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
Emmanuel Faure et al.
PLOS ONE (2014)
Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
Laurence Josset et al.
MBIO (2013)
Community acquired respiratory and gastrointestinal viral infections: challenges in the immunocompromised host
Anna Kaltsas et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Share Paper
